Pemoline in the Treatment of Stimulant Dependence - 5
NCT00000340 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to assess the efficacy of pemoline in treating cocaine and/or methamphetamine dependent adults with comorbid Adult Attention Deficit Hyperactivity Disorder (ADHD).
Conditions
- Cocaine-Related Disorders
Interventions
- DRUG
-
Pemoline
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Walter Ling, M.D. · Friends Research Institute, Inc.
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-06-30
More Related Trials
-
Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD)
NCT00514202 ·Status: TERMINATED ·Phase: PHASE2
-
[C-11]NPA PET-amphetamine in Cocaine Use Disorders
NCT05011760 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
NCT00000350 ·Status: UNKNOWN ·Phase: PHASE1
-
Studying Amphetamine Withdrawal in Humans
NCT01215929 ·Status: COMPLETED ·Phase: PHASE2
-
Understanding Dopamine Mechanisms in Cocaine Addiction Using AMPT and Methylphenidate With [11C]RAC/[11C]PHNO PET
NCT02152670 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder
NCT05529927 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Pemoline for Cocaine Abuse - 7
NCT00000282 ·Status: COMPLETED ·Phase: PHASE2
-
Phendimetrazine and Cocaine
NCT02233647 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Amphetamine Cocaine Interaction Study - 2
NCT00000305 ·Status: TERMINATED ·Phase: PHASE1
-
The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence
NCT01535937 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals
NCT00218062 ·Status: COMPLETED ·Phase: PHASE2
-
Citicoline Treatment of Methamphetamine Dependence
NCT00950352 ·Status: COMPLETED ·Phase: PHASE3
-
Modafinil vs Placebo for the Treatment of Methamphetamine Dependence
NCT00469508 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence
NCT00520286 ·Status: COMPLETED ·Phase: PHASE2
-
Methylphenidate for Cocaine Dependence
NCT03090269 ·Status: WITHDRAWN ·Phase: PHASE2
-
Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
NCT03059563 ·Status: TERMINATED ·Phase: PHASE1
-
Brain Mechanisms in Young Adults
NCT03606473 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Modafinil Treatment for Cocaine-Dependent Individuals
NCT00129285 ·Status: COMPLETED ·Phase: PHASE2
-
Prometa Pharmacotherapy for Methamphetamine Dependence
NCT00260481 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
NCT00218348 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Changes in Stimulant Dependent Subjects - 8
NCT00000343 ·Status: COMPLETED ·Phase: PHASE4
-
Agonist Replacement Therapy for Cocaine Dependence
NCT00697138 ·Status: COMPLETED ·Phase: PHASE1
-
Methylphenidate to Treat Methamphetamine Dependence
NCT01044238 ·Status: UNKNOWN ·Phase: PHASE2
-
Flupenthixol Decanoate in Methamphetamine Smoking - 1
NCT00000241 ·Status: COMPLETED ·Phase: PHASE2
-
Dextroamphetamine-Cocaine Behavioral Intervention - 5
NCT00000308 ·Status: COMPLETED ·Phase: PHASE2